TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

Versant Capital Management, Inc's Holding History (CIK: 0001735057)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 570 Value ($000) $22 Avg Close $32.52 Range $23.22 - $42.13

Q3 2025

Shares 570 Value ($000) $14 Avg Close $18.80 Range $14.36 - $28.69

Q2 2025

Shares 562 Value ($000) $8 Avg Close $16.57 Range $12.91 - $22.07

Q1 2025

Shares 590 Value ($000) $11 Avg Close $20.30 Range $16.80 - $25.29

Q4 2024

Shares 590 Value ($000) $10 Avg Close $17.69 Range $13.24 - $20.33

Q1 2024

Shares 61 Value ($000) $0 Avg Close $8.44 Range $7.11 - $10.27

Q2 2023

Shares 9 Value ($000) $0 Avg Close $18.19 Range $14.51 - $23.18

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	570	$22	$32.52	$23.22 - $42.13
Q3 2025	570	$14	$18.80	$14.36 - $28.69
Q2 2025	562	$8	$16.57	$12.91 - $22.07
Q1 2025	590	$11	$20.30	$16.80 - $25.29
Q4 2024	590	$10	$17.69	$13.24 - $20.33
Q1 2024	61	$0	$8.44	$7.11 - $10.27
Q2 2023	9	$0	$18.19	$14.51 - $23.18